BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/25/2024 8:28:58 AM | Browse: 155 | Download: 570
 |
Received |
|
2023-12-01 14:31 |
|
Peer-Review Started |
|
2023-12-01 14:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-07 02:51 |
|
Revised |
|
2023-12-15 15:16 |
|
Second Decision |
|
2024-01-03 03:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-01-03 07:10 |
|
Articles in Press |
|
2024-01-03 07:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-18 07:42 |
|
Publish the Manuscript Online |
|
2024-01-25 08:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Clinical and Translational Research |
| Article Title |
Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zi-Zheng Wu, Yuan-Jun Wei, Tong Li, Jie Zheng, Yin-Feng Liu and Meng Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Meng Han, MD, Director, Director, Breast Disease Diagnosis and Treatment Center, The First Hospital of Qinhuangdao, No. 258 Wenhua Road, Haigang District, Qinhuangdao 066000, Hebei Province, China. menghan68527@163.com |
| Key Words |
Breast cancer; Prognosis; Gene signature; The Cancer Genome Atlas; The Gene Expression Omnibus |
| Core Tip |
Breast cancer (BC), a leading malignant disease, affects women all over the world. Cancer associated fibroblasts (CAFs) stimulate epithelial-mesenchymal transition, and induce chemoresistance and immunosuppression. We introduced a newly-discovered CAFs-associated gene signature using IL18, MYD88, GLIPR1, TNN, BHLHE41, DNAJB5, FKBP14, and XG, which can be employed to estimate BC patient outcomes conveniently and accurately. |
| Publish Date |
2024-01-25 08:28 |
| Citation |
ZZ Wu, YJ Wei, Li T, Zheng J, Liu YF, Han M. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer. World J Clin Cases 2024; 12(4): 700-720 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i4/700.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i4.700 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
